Serous Cystadenocarcinoma of the Pancreas: Clinical Features and Management of a Rare Tumor

12Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background/Aims: The vast majority of serous cystic neoplasms of the pancreas are benign, and small, asymptomatic lesions, which are generally managed with observation. However, some of these tumors may attain a large size and occasionally metastasize. Methods: In this study, we present a 78-year-old man with serous cystadenocarcinoma of the pancreas with liver metastases treated by distal pancreatectomy and liver ablation, who went on to develop new liver metastases 5 years after the initial operation. We perform a literature review to determine the number of these malignant neoplasms previously reported and to identify features associated with malignant lesions. Results: Literature reveals that metastatic serous cystadenocarcinomas of the pancreas are rare tumors, occurring in less than 3% of cases of serous cystic neoplasms. All malignant cases reported have been in tumors >4 cm in size. Conclusions: Serous cystic neoplasms of the pancreas >4 cm have malignant potential and therefore should be considered for surgical management.

Cite

CITATION STYLE

APA

Van Dyke, T. J., Johlin, F. C., Bellizzi, A. M., & Howe, J. R. (2016, April 1). Serous Cystadenocarcinoma of the Pancreas: Clinical Features and Management of a Rare Tumor. Digestive Surgery. S. Karger AG. https://doi.org/10.1159/000444721

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free